History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.
about
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findingsCannabis and psychosis: NeurobiologyAddiction is Not a Natural KindImaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivityStriatocortical pathway dysfunction in addiction and obesity: differences and similaritiesCannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severityDrugs of abuse and increased risk of psychosis development.Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.Neuroimaging of the dopamine/reward system in adolescent drug use.Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum.AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokersReduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers.Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers.The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.The effects of Δ9-tetrahydrocannabinol on the dopamine system.Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis useA review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate.Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential.Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.Is Addiction a Heterogeneous Condition? Reflections on Pickard's “The Purpose in Chronic Addiction”
P2860
Q21559698-BBAE9BD9-7C68-4CED-AECC-4027AE8B7744Q27024404-50F2D400-4D0A-4F80-A0AE-412E9DB0776FQ30354281-E5500C3D-C2CA-437C-BABB-7DC22F42F72DQ30422045-F5816C20-10F4-4746-9C96-52F53CF4F6C1Q30578245-FF70DC5E-852D-4511-81F8-89483BCB6EFFQ33819365-C5E37C08-057D-4A58-8938-6DF231FBDF92Q34002281-12E210D0-1747-4DC8-ADB5-675014B27EEBQ34290364-F9F92E13-5F05-4CBA-9AA0-EC0EF54E3266Q35982298-1E7E7BD3-272F-4C16-950B-CA656B974107Q36030702-6146C5EA-3D61-4448-9AAB-14AE8556BA4DQ36234294-93815C3A-F628-48D4-AD41-E03C6BB87685Q36496045-6667BA16-E636-4ED7-A73C-68E82B00D602Q36610068-D23A53D0-DFD4-42E1-909C-886B0A76BF6DQ36751811-113BC2C2-5B1D-4048-BA1E-7598B0A12023Q36915433-8AC24E6A-3057-4778-A2A3-EA559FB9F928Q36915496-047E9EB5-06DF-477A-A14E-021BF3B35201Q37281925-D79BEA8B-E179-49AA-8C4D-C8C6C0CFED7DQ37425054-8E8CE2FF-EB51-458E-97B4-A276CC8D7F92Q37441554-BD2933B7-FA98-4B34-BC75-995F4579AFFEQ37705759-1FD8BFE8-2CF8-4606-9BC3-52D9205C83A8Q38789021-0D8E2C4A-5276-4C8C-9942-DBCDB5D1AA67Q40944292-2A5553F6-D286-4EEA-8A7B-43F7C194EF46Q46050621-2A54350B-33AD-45F3-ABBC-B28EDDD4B325Q50082799-5DCDDBA0-CE26-464E-AB4A-A54F15D02151Q50592444-09A0628A-93ED-4FD4-81DA-4D9719C2B4E9Q52625218-4250ACF5-512B-4DF4-865A-90B4570A4047Q58246744-46FAB970-8822-4F61-ABFD-56C6963FB92C
P2860
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
History of cannabis use is not ...... e D2/D3 receptor availability.
@en
History of cannabis use is not ...... e D2/D3 receptor availability.
@nl
type
label
History of cannabis use is not ...... e D2/D3 receptor availability.
@en
History of cannabis use is not ...... e D2/D3 receptor availability.
@nl
prefLabel
History of cannabis use is not ...... e D2/D3 receptor availability.
@en
History of cannabis use is not ...... e D2/D3 receptor availability.
@nl
P2093
P2860
P50
P356
P1476
History of cannabis use is not ...... e D2/D3 receptor availability.
@en
P2093
Alice Egerton
Alistair Reid
Anne R Lingford-Hughes
Ben Watson
P2860
P304
P356
10.1177/0269881111414090
P407
P577
2011-09-02T00:00:00Z